- Home
- OVID vs IZTC Comparison
OVID vs IZTC Comparison
Compare OVID & IZTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVID
- IZTC
- Stock Information
- Founded
- OVID 2014
- IZTC 2019
- Country
- OVID United States
- IZTC United States
- Employees
- OVID N/A
- IZTC N/A
- Industry
- OVID Biotechnology: Pharmaceutical Preparations
- IZTC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OVID Health Care
- IZTC Health Care
- Exchange
- OVID Nasdaq
- IZTC Nasdaq
- Market Cap
- OVID 73.1M
- IZTC 69.5M
- IPO Year
- OVID 2017
- IZTC 2024
- Fundamental
- Price
- OVID $1.02
- IZTC $16.21
- Analyst Decision
- OVID Strong Buy
- IZTC
- Analyst Count
- OVID 5
- IZTC 0
- Target Price
- OVID $4.04
- IZTC N/A
- AVG Volume (30 Days)
- OVID 210.4K
- IZTC 32.5K
- Earning Date
- OVID 11-12-2024
- IZTC 01-01-0001
- Dividend Yield
- OVID N/A
- IZTC N/A
- EPS Growth
- OVID N/A
- IZTC N/A
- EPS
- OVID N/A
- IZTC N/A
- Revenue
- OVID $631,695.00
- IZTC N/A
- Revenue This Year
- OVID $71.38
- IZTC N/A
- Revenue Next Year
- OVID $5,144.81
- IZTC N/A
- P/E Ratio
- OVID N/A
- IZTC N/A
- Revenue Growth
- OVID 113.21
- IZTC 145.01
- 52 Week Low
- OVID $0.68
- IZTC $8.50
- 52 Week High
- OVID $4.10
- IZTC $19.37
- Technical
- Relative Strength Index (RSI)
- OVID 44.47
- IZTC N/A
- Support Level
- OVID $1.00
- IZTC N/A
- Resistance Level
- OVID $1.09
- IZTC N/A
- Average True Range (ATR)
- OVID 0.08
- IZTC 0.00
- MACD
- OVID -0.00
- IZTC 0.00
- Stochastic Oscillator
- OVID 27.27
- IZTC 0.00
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.